HPLC-Based Activity Profiling Approach for the Discovery of GABA_A Receptor Ligands using an Automated Two Microelectrode Voltage Clamp Assay on Xenopus Oocytes

Abstract

An approach for rapid HPLC-based profiling for new GABA_A ligands of natural origin has been developed. Active extracts are separated by a single injection of 3 - 10 mg of extract onto a semi-preparative (150 × 10 mm i. d.) HPLC column with gradient elution and time-based fractionation. The microfractions are tested in an automated two-microelectrode voltage-clamp assay on Xenopus oocytes expressing recombinant GABA_A channels composed of α₁, β₂ and γ_2S subunits. The protocol has been validated by spiking experiments with inactive extract and the GABA_A receptor ligand magnolol, and by profiling of active extracts such as valerian extract containing the known GABA_A receptor ligand valerenic acid. For dereplication of GABA containing extracts, we established a rapid and simple procedure by which GABA is analyzed as OPA derivative by reversed-phase HPLC. This dereplication protocol was validated with plant and fungal extracts which had been previously tested active or inactive in the oocyte assay and with spiking experiments.

Abbreviations

GABA:γ-aminobutyric acid

OPA:o-phthaldialdehyde

Key words

GABA_A receptor ligand - microelectrode voltage-clamp assay - Xenopus oocytes - HPLC actvity profiling - dereplication - lead discovery

References

• 1 Barnard E A, Skolnick P, Olsen R W, Mohler H, Sieghart W, Biggio G. et al . International Union of Pharmacology. XV. Subtypes of γ-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function.  Pharmacol Rev. 1998;  50 291-313
• 2 Hevers W, Luddens H. The diversity of GABA_A receptors: Pharmacological and electrophysiological properties of GABA_A channel subtypes.  Mol Neurobiol. 1998;  18 35-86
• 3 Bonnert T P, McKernan R M, Farrar S, le Bourdellès B, Heavens R P, Smith D W. et al . Θ, a novel γ-aminobutyric acid type A receptor subunit.  Proc Natl Acad Sci USA. 1999;  96 9891-6
• 4 Benke D, Mertens S, Trzeciak A, Gillessen D, Mohler H. GABA_A receptors display association of γ2-subunit with α1- and β2/3-subunits.  J Biol Chem. 1991;  266 4478-83
• 5 Benke D, Fritschy J M, Trzeciak A, Bannwarth W, Mohler H. Distribution, prevalence, and drug binding profile of γ-aminobutyric acid type A receptor subtypes differing in the β-subunit variant.  J Biol Chem. 1994;  269 27 100-7
• 6 Boileau A J, Baur R, Sharkey L M, Sigel E, Czajkowski C. The relative amount of cRNA coding for γ2 subunits affects stimulating by benzodiazepines in GABA_A receptors expressed in Xenopus oocytes.  Neuropharmacology. 2002;  43 695-700
• 7 Hobbs W R, Rall T W, Verdoorn T A. In: Hardmann J, Limbird L, editors Goodman and Gilman’s the pharmacological basis of therapeutics. Columbus; McGraw-Hill Companies Inc. 1996: 361-98
• 8 Whiting P J. GABA-A receptors: a viable target for novel anxiolytics?.  Curr Opin Pharmacol. 2006;  6 24-9
• 9 Medina J H, Pena C, Levi de Stein M, Wolfman C, Paladini A C. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants.  Biochem Biophys Res Commun. 1989;  165 547-53
• 10 Stephenson F A. The GABA_A receptors.  Biochem J. 1995;  310 1-9
• 11 Höld K M, Sirisoma N S, Ikeda T, Narahashi T, Casida J E. α-Thujone (the active component of absinthe): γ-aminobutyric acid type A receptor modulation and metabolic detoxification.  Proc Natl Acad Sci USA. 2000;  97 3826-31
• 12 Nielsen M, Frokjaer S, Braestrup C. High affinity of the natrually-occurring biflavonoid, amentoflavone, to brain benzodiazepine receptors in vitro.  Biochem Pharmacol. 1988;  37 3285-7
• 13 Ai J, Dekermendjian K, Wang X, Nielsen M, Witt M R. 6-Methylflavone, a benzodiazepine receptor ligand with antagonistic properties on rat brain and human recombinant GABA_A receptors in vitro.  Drug Develop Res. 1997;  41 99-106
• 14 Tsang S Y, Xue H. Development of effective therapeutics targeting the GABA_A receptor: naturally occurring alternatives.  Curr Pharm Design. 2004;  10 1035-44
• 15 Khom S, Baburin I, Timin E, Hohaus A, Trauner G, Kopp B. et al . Valerenic acid potentiates and inhibits GABA_A receptors: Molecular mechanism and subunit specificity.  Neuropharmacology. 2007;  53 178-87
• 16 Baur R, Simmen U, Senn M, Séquin U, Sigel E. Novel plant substances acting as β subunit isoform-selective positive allosteric modulators of GABA_A receptors.  Mol Pharmacol. 2005;  68 787-92
• 17 Huen M S, Hui K M, Leung J W, Sigel E, Baur R, Wong J T. et al . Naturally occurring 2′-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands.  Biochem Pharmacol. 2003;  66 2397-407
• 18 Hansen R S, Paulsen I, Davis M. Determinants of amentoflavone interaction at the GABA_A receptor.  Eur J Pharmacol. 2005;  519 199-207
• 19 Potterat O, Hamburger M. Natural products in drug discovery - concepts and approaches for tracking bioactivity.  Curr Org Chem. 2006;  10 899-920
• 20 Danz H, Stoyanova S, Wippich P, Brattström A, Hamburger M. Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria.  Planta Med. 2001;  67 411-6
• 21 Dittmann K, Gerhäuser C, Klimo K, Hamburger M. HPLC-based activity profiling of Salvia miltiorrhiza for MAO A and iNOS inhibitory activities.  Planta Med. 2004;  70 909-13
• 22 Hamburger M, Rüster G U, Melzig M F. HPLC based activity profiling for inhibitors of human neutrophil elastase in Isatis tinctoria leaf extracts.  Nat Prod Commun. 2006;  1 1107-10
• 23 Moret S, Populin T, Conte L S, Cosens G. HPLC determination of free nitrogenous compounds of Centaurea solstitialis (Asteraceae), the cause of equine nigropallidal encephalomalacia.  Toxicon. 2005;  46 651-7
• 24 Khom S, Baburin I, Timin E N, Hohaus A, Sieghart W, Hering S. Pharmacological properties of GABA_A receptors containing γ1 subunits.  Mol Pharmacol. 2006;  69 640-9
• 25 Methfessel C, Witzemann V, Takahashi T, Mishina M, Numa S, Sakmann B. Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels.  Pflugers Arch. 1986;  407 577-88
• 26 Hering S. Small-volume and rapid extracellular solution exchange around Xenopus oocytes during voltage-clamp recordings.  Pflugers Arch. 1998;  436 303-7
• 27 Baburin I, Beyl S, Hering S. Automated fast perfusion of Xenopus oocytes for drug screening.  Pflugers Arch Eur J Physiol. 2006;  453 117-23
• 28 Squires R F, Ai J, Witt M R, Kahnberg P, Saederup E, Sterner O. et al . Honokiol and magnolol increase the number of [³H]muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites.  Neurochem Res. 1999;  24 1593-602
• 29 Yuan C -S, Mehendale S, Xiao Y, Aung H H, Xie J T, Ang-Lee M K. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity.  Anesth Analg. 2004;  98 353-8
• 30 Schumacher B, Scholle S, Hölzl J, Khudeir N, Hess S, Müller C E. Lignans isolated from Valerian: Identification and characterization of a new olivil dervivative with partial agonistic activity at A1 adenosine receptors.  J Nat Prod. 2002;  65 1479-85
• 31 Navarrete A, Avula B, Choi Y -W, Khan I A. Chemical fingerprinting of Valeriana species: simultaneous determination of valerenic acids, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection.  J AOAC Int. 2006;  89 8-15